Bioidentical vs. Conventional Hormones: What the Science Says

Walk through any health and wellness section of the internet, and you'll encounter bold claims for "bioidentical" or "natural" hormones — often positioned as a safer, more effective alternative to "synthetic" hormone therapy. The marketing is persuasive. The science tells a more complicated story.

Understanding what "bioidentical" actually means — and what the medical evidence actually shows — empowers you to have informed conversations with your provider.

What "Bioidentical" Actually Means

In the strictest scientific sense, a hormone is "bioidentical" if its molecular structure is identical to a hormone naturally produced by the human body. By this definition:

• 17β-estradiol (the primary estrogen produced by the ovaries) is bioidentical
• Micronized progesterone (Prometrium) is bioidentical
• Synthetic progestins like medroxyprogesterone acetate (MPA) are not bioidentical — they have a different molecular structure

Here's what the wellness industry often obscures: many FDA-approved hormone therapy products already contain bioidentical hormones. Estrace (estradiol pills), Vivelle-Dot (estradiol patch), Divigel (estradiol gel), and Prometrium (micronized progesterone) are all bioidentical by the scientific definition — and all are FDA-approved.

FDA-Approved vs. Compounded Bioidentical Hormones

The marketing confusion typically centers on the distinction between two very different categories:

FDA-approved bioidentical hormones undergo rigorous clinical testing for safety, efficacy, and manufacturing consistency. The FDA regulates the quality, dosing, and labeling of these products. This is the evidence-based category.

Compounded bioidentical hormone therapy (CBHT) refers to custom preparations made at compounding pharmacies, typically combining multiple hormones in formulations not available commercially. These include:

• Bi-est (combination of estradiol and estriol)
• Tri-est (estradiol, estrone, estriol)
• Custom progesterone creams
• Combinations of DHEA, testosterone, and estrogens

What ACOG, NAMS, and the FDA Say

The three most authoritative medical bodies on this topic have taken clear positions:

The FDA has issued guidance noting that claims of superiority or safety for compounded over FDA-approved hormones are not supported by evidence, and that compounded drugs lack the safety and efficacy data that FDA-approved drugs possess.

ACOG states that it does not support the use of compounded hormone therapy, given the lack of evidence for superior efficacy or safety compared to FDA-approved products.

NAMS similarly recommends FDA-approved hormone therapy as the preferred approach, noting that claims for CBHT — including customization, natural superiority, and "exact matching" to individual hormone levels — are not supported by peer-reviewed evidence.

The Saliva Testing Problem

A common feature of CBHT practices is the use of saliva hormone testing to guide dosing. The appeal is intuitive — personalized testing for personalized treatment. The science does not support this approach.

Hormone levels in saliva fluctuate significantly throughout the day and are affected by diet, hydration, and other factors. No regulatory body has validated saliva testing as a reliable method for determining menopausal hormone therapy dosing. Studies have not demonstrated that dosing based on saliva tests produces better outcomes than standard clinical approaches.

A Note on Estriol

Estriol is a weaker estrogen sometimes included in compounded preparations (bi-est, tri-est). It is not included in FDA-approved menopausal hormone therapy because it has not been shown to provide additional benefit over estradiol alone. Some compounding pharmacies market it as "safer," but this claim is not supported by robust clinical evidence.

Testosterone: A Special Case

Testosterone therapy for women with hypoactive sexual desire disorder (HSDD) represents a separate discussion. No testosterone product is FDA-approved specifically for use in women in the United States, though testosterone therapy may be prescribed off-label. This is a legitimate area of evolving evidence — distinct from the CBHT marketing claims.